AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.
Ogilvy
C S
CS
Stieg
P E
PE
Awad
I
I
Brown
R D
RD
Kondziolka
D
D
Rosenwasser
R
R
Young
W L
WL
Hademenos
G
G
D000572:American Heart Association; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002548:Cerebral Revascularization / Q000592:standards*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000592:standards*; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D015994:Incidence; D002538:Intracranial Arteriovenous Malformations / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D020300:Intracranial Hemorrhages / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008910:Minnesota; D009426:Netherlands; D015995:Prevalence; D016634:Radiosurgery / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018570:Risk Assessment; D012640:Seizures / Q000209:etiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000959:Antihypertensive Agents